Newsmakers
NY Comptrollers, CalSTRS Retaliate Against Mylan Board
A recently filed form reveals the EpiPen company ignored majority shareowner votes again, and the response is ferocious.
A recently filed form reveals the EpiPen company ignored majority shareowner votes again, and the response is ferocious.
Although shareholders voted against Management Proposal 5, the directors remain.
New York City Pension Funds lead the charge against Management Proposal 5 with Glass Lewis, ISS’s endorsement as they prep for Mylan’s June 22 shareholder meeting.
Decision comes one year after divesting from US coal holdings.
Growing investor frustrations at the company’s annual meeting suggests change is imminent, but the board’s history makes implementation unlikely.